tbuckley/cabot-search huggingface dataset:
TCT-677 Evaluating Ischemia With Nonobstructive Coronary Arteries Using Invasive Coronary Function Testing: Insights From the DISCOVER INOCA Multicenter Registry
Authors: Samit Shah, Jennifer Tremmel, Nathaniel Smilowitz, Megha Prasad, Yuhei Kobayashi, Timothy Henry, Glen Henry, Habib Samady, Bruce Samuels, Amir Lerman, Jeffrey Moses, Cody Pietras, Zhiyuan Zhang, Daniela Tirziu, Helen Parise, Ecaterina Cristea, Daniel Chamie, Kyna Henrici, Nida Latif, Natasha Cigarroa, Alexandra Lansky
Journal: Journal of the American College of Cardiology (2024)
TCT-662 Influence of Comorbidities and Lesion Characteristics on the Diagnostic Performance of Non-Hyperemic Diagnostic Metrics in Coronary Artery Disease
Authors: Jinying Zhou, Xutan Qin, Jingpu Wang, Hao Lu, Feng Zhang, TsungYing Tsai, Paddy Murphy, Akihiro Tobe, Juying Qian, Patrick Serruys, Junbo Ge
Journal: Journal of the American College of Cardiology (2024)
TCT-680 Myocardial Infarction With Non-Obstructive Coronary Arteries (MINOCA): Full Clinical Picture, Risk Factors, and NT-proBNP/Troponin Ratio as a Novel Diagnostic Method
Authors: Natalia Krajewska, Lukasz Koltowski, Damian Waląg
Journal: Journal of the American College of Cardiology (2024)
TCT-609 Mortality Trends Due to Non-Rheumatic Valvular Disease Among Adults in the United States From Year 1999-2020: CDC WONDER Database Survey Analysis
Authors: Mobeen Haider, Muhammad Abdullah Naveed, Faizan Ahmed, Muhammad Omer Rehan, Syed Ishaq, Ahila Ali, Manahil Mubeen
Journal: Journal of the American College of Cardiology (2024)
TCT-740 The Impact of Limited English Proficiency on Pulmonary Embolism Management and Outcomes
Authors: Lucas Walz, Robert Zilinyi, Daniel Snyder, Mahesh Madhavan, Abigail Graham, Joshua Fuller, Varun Sudunagunta, Junduo Liu, Ryan Leone, Christine Yang, Justin Fried, Erika Berman Rosenzweig, Koji Takeda, Daniel Burkhoff, Ajay Kirtane, Sahil Parikh, Sanjum Sethi
Journal: Journal of the American College of Cardiology (2024)
TCT-681 Impact of Antiplatelet Therapy on 5-Year Outcomes After Fractional Flow Reserve–Guided Deferral of Revascularization in Nonsignificant Obstructive Coronary Artery Disease: A Substudy of the J-CONFIRM Registry
Authors: Shoichi Kuramitsu, Hitoshi Matsuo, Nobuhiro Tanaka
Journal: Journal of the American College of Cardiology (2024)
TCT-705 Comparative Outcomes of Endovascular Intervention Versus Bypass Surgery for Peripheral Artery Disease in Patients With Atrial Fibrillation: A Retrospective Analysis of the National Inpatient Sample
Authors: Olayiwola Bolaji, Prakash Upreti, Rakesh Shah, Ritu Yadav, George Kidess, Jawad Basit, Yasar Sattar, M. Chadi Alraies
Journal: Journal of the American College of Cardiology (2024)
TCT-693 Clinical Outcome of Between Low- and High-Dose Drug-Coated Balloon Angioplasty Performing Intraplaque Wiring for Femoropopliteal Artery Chronic Total Occlusion Lesions
Authors: Narumi Taninobu, Kazunori Mushiake, Hiroyuki Tanaka, Kazushige Kadota, Yuki Shima
Journal: Journal of the American College of Cardiology (2024)
TCT-668 Use of Antiplatelet Agents in Patients With Myocardial Bridge: Insights From the RIALTO Registry
Authors: Domenico D'Amario, Renzo Laborante, Gaetano Rizzo, Giuseppe Ciliberti, Donato Antonio Paglianiti, Domenico Cicchella, Fabio Casamassima, Carlo Trani, Francesco Burzotta, Cristina Aurigemma, Enrico Romagnoli, Antonio Maria Leone, Filippo Crea, Italo Porto, Rocco Vergallo, Gianluca Campo, Simone Biscaglia, Iacopo Farina, Gianluca Anastasia, Giuseppe Massimo Sangiorgi, Gianluca Massaro, Giuseppe Patti
Journal: Journal of the American College of Cardiology (2024)
TCT-692 First Clinical Use of a Novel Forward-Shifted Peripheral Intravascular Lithotripsy System: Primary Outcomes of the Mini S/FORWARD PAD IDE Study
Authors: John Corl, Daniel Clair, Nicolas Shammas, Peter Soukas, Anderson Mehrle, Anvar Babaev, Iftekhar Baig, Ryan Shields, Nick West, Andrew Holden
Journal: Journal of the American College of Cardiology (2024)
TCT-648 HFpEF Phenotype Is Associated With Early Symptom Onset in Aortic Stenosis and Residual Symptomatic Burden After Transcatheter Aortic Valve Replacement
Authors: Constantijn Venema, Kees van Bergeijk, Jan Krikken, Hindrik van der Werf, Ad van den Heuvel, Yvonne Douglas, Ify Mordi, Nicolas Girerd, Chim Lang, Martin Leon, Carolyn Lam, Erik Lipsic, Adriaan Voors, Joanna Wykrzykowska
Journal: Journal of the American College of Cardiology (2024)
TCT-97 A Meta-Analysis of Cardioneuroablation Efficacy in Achieving Syncope Freedom in Neurocardiogenic Syncope
Authors: Ricky E. Lemus-Zamora, Abdul Mueez Alam Kayani, Alan Garcia, Miriam Ramirez-Rojas, Jorge Gomez-Flores
Journal: Journal of the American College of Cardiology (2024)
TCT-626 The Impact of Post-Implantation Leaflet Height on Mitral Regurgitation Recurrence After MitraClip for Degenerative Disease
Authors: Cheng Wang, Nadira Hamid, Davide Margonato, Atsushi Okada, Miho Fukui, Asa Phichaphop, Vinayak Bapat, John Lesser, Maurice Enriquez-Sarano, Joao Cavalcante, Paul Sorajja
Journal: Journal of the American College of Cardiology (2024)
Neurodevelopmental Disorder Caused by Deletion of <i>CHASERR</i> , a lncRNA Gene
Authors: Vijay S. Ganesh, Kevin Riquin, Nicolas Chatron, Esther Yoon, Kay-Marie Lamar, Miriam C. Aziz, Pauline Monin, Melanie C. O’Leary, Julia K. Goodrich, Kiran V. Garimella, Eleina England, Ben Weisburd, François Aguet, Carlos A. Bacino, David R. Murdock, Hongzheng Dai, Jill A. Rosenfeld, Lisa T. Emrick, Shamika Ketkar, Yael Sarusi, Damien Sanlaville, Saima Kayani, Brian Broadbent, Alisée Pengam, Bertrand Isidor, Stéphane Bezieau, Benjamin Cogné, Daniel G. MacArthur, Igor Ulitsky, Gemma L. Carvill, Anne O’Donnell-Luria
Journal: New England Journal of Medicine (2024)

encodes a human long noncoding RNA (lncRNA) adjacent to
TCT-729 Thirty-Day Outcome of Pharmacomechanical Devices in Treating Intermediate-Risk Pulmonary Embolization: Real-World Data From Two Medical Centers
Authors: Nicolas Shammas, William Sharis, George Mankarious, Yoshitha Inala, Morgan Janes, Gail Shammas, Sue Jones-Miller, Cara Voelliger
Journal: Journal of the American College of Cardiology (2024)
TCT-95 In-Hospital, 1-Year, and Intermediate Outcomes of Patients With Paradoxical Low-Flow, Low-Gradient Aortic Stenosis Treated With Transcatheter Aortic Valve Replacement
Authors: Vincent Lipari, Sean McMahon, Jeff Mather, Nicole Hoover, Jawad Haider, Robert Hagberg, Raymond McKay
Journal: Journal of the American College of Cardiology (2024)
TCT-597 Evaluation of Renal Functional Reserve in Patients With Coronary Microvascular Dysfunction and Preserved Renal Function
Authors: Margarita Bora, Kyriakos Dimitriadis, Athanasios Sakalidis, Panagiota Giannou, Athanasia Kapota, Aikaterini Damianaki, Aglaia Chalkia, Dimitris Kourniotis, Zoi Alexakou, Ioannis Leontsinis, Ioannis Ntalakouras, Konstantinos Aznaouridis, Dimitrios Petras, Konstantinos Tsioufis
Journal: Journal of the American College of Cardiology (2024)
TCT-602 Association Between the Severity of Coronary Artery Stenosis and the Minimum Responsive Dose of Intracoronary Provocation Test
Authors: Woo Jin Ahn, Seung-Woon Rha, Se Yeon Choi, Jinah Cha, Sujin Hyun, Byoung Geol Choi, Markz Sinurat, Soohyung Park, Chang Gyu Park, Dong Joo Oh, Cheol Ung Choi
Journal: Journal of the American College of Cardiology (2024)
TCT-102 First-in-Man Experience With the Self-Expandable A-Flux Coronary Sinus Reducer for Treating Symptomatic Ischemic Heart Disease
Authors: Jean-Michel Paradis, Salvatore Brugaletta, Jose Antonio Baz Alonso, Neil Fam, Omar Abdul-Jawad Altisent, Julio Farjat Pasos, Juan del Portillo, Francesco Gallo, Josep Rodes-Cabau, Rishi Puri, Victor Alfonso Jimenez Diaz, Francesco Giannini
Journal: Journal of the American College of Cardiology (2024)
TCT-694 A New Paradigm in the Treatment of Peripheral Arterial Disease: Optimizing Endovascular Procedural Efficiency Through Primary Transpedal Access
Authors: Justin Ratcliffe, Krista Curcio, Pankaj Khullar, Samuel Wietschner, Philip Green, Shayan Nabavi Nouri, Andrew Swift, GraceAnn Kinsale, Heny Puma, Mohamed Domane, Gustavo Soto, Michael Shapiro
Journal: Journal of the American College of Cardiology (2024)
Revealing transparency gaps in publicly available COVID-19 datasets used for medical artificial intelligence development—a systematic review
Authors: Joseph E Alderman, Maria Charalambides, Gagandeep Sachdeva, Elinor Laws, Joanne Palmer, Elsa Lee, Vaishnavi Menon, Qasim Malik, Sonam Vadera, Melanie Calvert, Marzyeh Ghassemi, Melissa D McCradden, Johan Ordish, Bilal Mateen, Charlotte Summers, Jacqui Gath, Rubeta N Matin, Alastair K Denniston, Xiaoxuan Liu
Journal: The Lancet Digital Health (2024)
The effect of Plasmodium falciparum exposure and maternal anti-circumsporozoite protein antibodies on responses to RTS,S/AS01E vaccination in infants and children: an ancillary observational immunological study to a phase 3, randomised clinical trial
Authors: Dídac Macià, Joseph J Campo, Chenjerai Jairoce, Maximilian Mpina, Hermann Sorgho, David Dosoo, Selidji Todagbe Agnandji, Kwadwo Asamoah Kusi, Luis M Molinos-Albert, Simon Kariuki, Claudia Daubenberger, Benjamin Mordmüller, Gemma Moncunill, Carlota Dobaño
Journal: The Lancet Infectious Diseases (2024)
Unleashing the strengths of unlabelled data in deep learning-assisted pan-cancer abdominal organ quantification: the FLARE22 challenge
Authors: Jun Ma, Yao Zhang, Song Gu, Cheng Ge, Shihao Mae, Adamo Young, Cheng Zhu, Xin Yang, Kangkang Meng, Ziyan Huang, Fan Zhang, Yuanke Pan, Shoujin Huang, Jiacheng Wang, Mingze Sun, Rongguo Zhang, Dengqiang Jia, Jae Won Choi, Natália Alves, Bram de Wilde, Gregor Koehler, Haoran Lai, Ershuai Wang, Manuel Wiesenfarth, Qiongjie Zhu, Guoqiang Dong, Jian He, Bo Wang
Journal: The Lancet Digital Health (2024)
Immunogenicity of a booster dose of a bivalent (Asp614Gly and omicron BA.4/5 variant) self-amplifying mRNA SARS-CoV-2 booster vaccine versus the BNT162b2 omicron BA.4/5 mRNA vaccine: a randomised phase 3 trial
Authors: Yusuke Okada, Yuji Kumagai, Iori Okura, Mako Otsuki, Natsuki Ishida, Yasuhiro Iwama, Takeshi Minamida, Yukihiro Yagi, Toru Kurosawa, Josephine van Boxmeer, Ye Zhang, Igor Smolenov, Judd L Walson
Journal: The Lancet Infectious Diseases (2024)
COVID-19 testing and reporting behaviours in England across different sociodemographic groups: a population-based study using testing data and data from community prevalence surveillance surveys
Authors: Sumali Bajaj, Siyu Chen, Richard Creswell, Reshania Naidoo, Joseph L-H Tsui, Olumide Kolade, George Nicholson, Brieuc Lehmann, James A Hay, Moritz U G Kraemer, Ricardo Aguas, Christl A Donnelly, Tom Fowler, Susan Hopkins, Liberty Cantrell, Prabin Dahal, Lisa J White, Kasia Stepniewska, Merryn Voysey, Ben Lambert
Journal: The Lancet Digital Health (2024)
Artificial intelligence-enabled electrocardiogram for mortality and cardiovascular risk estimation: a model development and validation study
Authors: Arunashis Sau, Libor Pastika, Ewa Sieliwonczyk, Konstantinos Patlatzoglou, Antoônio H Ribeiro, Kathryn A McGurk, Boroumand Zeidaabadi, Henry Zhang, Krzysztof Macierzanka, Danilo Mandic, Ester Sabino, Luana Giatti, Sandhi M Barreto, Lidyane do Valle Camelo, Ioanna Tzoulaki, Declan P O'Regan, Nicholas S Peters, James S Ware, Antonio Luiz P Ribeiro, Daniel B Kramer, Jonathan W Waks, Fu Siong Ng
Journal: The Lancet Digital Health (2024)
Association of holidays and the day of the week with suicide risk: multicounty, two stage, time series study
Authors: Whanhee Lee, Cinoo Kang, Chaerin Park, Michelle L Bell, Ben Armstrong, Dominic Roye, Masahiro Hashizume, Antonio Gasparrini, Aurelio Tobias, Francesco Sera, Yasushi Honda, Aleš Urban, Jan Kyselý, Carmen Íñiguez, Niilo Ryti, Yuming Guo, Shilu Tong, Micheline de Sousa Zanotti Stagliorio Coelho, Eric Lavigne, Francesca de'Donato, Yue Leon Guo, Joel Schwartz, Alexandra Schneider, Susanne Breitner, Yeonseung Chung, Sooin Kim, Eunhee Ha, Ho Kim, Yoonhee Kim
Journal: BMJ (2024)

Abstract Objectives To assess the short term temporal variations in suicide risk related to the day of the week and national holidays in multiple countries. Design Multicountry, two stage, time series design. Setting Data from 740 locations in 26 countries and territories, with overlapping periods between 1971 and 2019, collected from the Multi-city Multi-country Collaborative Research Network database. Participants All suicides were registered in these locations during the study period (overall 1 701 286 cases). Main outcome measures Daily suicide mortality. Results Mondays had peak suicide risk during weekdays (Monday-Friday) across all countries, with relative risks (reference: Wednesday) ranging from 1.02 (95% confidence interval (CI) 0.95 to 1.10) in Costa Rica to 1.17 (1.09 to 1.25) in Chile. Suicide risks were lowest on Saturdays or Sundays in many countries in North America, Asia, and Europe. However, the risk increased during weekends in South and Central American countries, Finland, and South Africa. Additionally, evidence suggested strong increases in suicide risk on New Year’s day in most countries with relative risks ranging from 0.93 (95% CI 0.75 to 1.14) in Japan to 1.93 (1.31 to 2.85) in Chile, whereas the evidence on Christmas day was weak. Suicide risk was associated with a weak decrease on other national holidays, except for Central and South American countries, where the risk generally increased one or two days after these holidays. Conclusions Suicide risk was highest on Mondays and increased on New Year’s day in most countries. However, the risk of suicide on weekends and Christmas varied by country and territory. The results of this study can help to better understand the short term variations in suicide risks and define suicide prevention action plans and awareness campaigns.
Efficacy and Safety of Upadacitinib vs Dupilumab in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: Week 16 results of an Open-label, Randomized, Efficacy Assessor-Blinded Head-to-Head Phase 3b/4 Study (Level Up)
Authors: Jonathan I Silverberg, Christopher G Bunick, H Chih-ho Hong, Pedro Mendes-Bastos, Linda Stein Gold, Antonio Costanzo, Nadia Ibrahim, Cristina Sancho, Xiaoqiang Wu, Yu Han, Gweneth Levy, Kathy Altman, Brian Calimlim, Kilian Eyerich
Journal: British Journal of Dermatology (2024)

Abstract Background Atopic dermatitis (AD) is a chronic skin disease characterized by intense itch and eczematous skin lesions. Some patients with AD continue to experience flares and substantial clinical burden, despite ongoing systemic treatment. Objectives To assess the efficacy and safety of once-daily upadacitinib (UPA), initiated at 15 mg and dose-escalated to 30 mg based on clinical response, compared with dupilumab (DUPI) as per its label, and present the week 16 primary analysis results. Methods Level Up is a phase IIIb/IV global randomized open-label efficacy assessor-blinded study evaluating UPA vs. DUPI in adolescents and adults with moderate-to-severe AD who had an inadequate response to systemic therapy or when use was inadvisable. Patients were randomized to UPA or DUPI for 16 weeks of treatment (period 1). Patients on UPA were started on 15 mg and dose-escalated to 30 mg if they did not achieve an Eczema Area and Severity Index reduction of at least 50% (EASI 50) or a ≥ 4-point Worst Pruritus Numerical Rating Scale (WP-NRS) improvement on or after week 4, or an EASI reduction of at least 75% (EASI 75) on or after week 8. The primary endpoint was simultaneous achievement of an EASI reduction of at least 90% (EASI 90) and WP-NRS 0/1 at week 16. Ranked secondary endpoints included skin and itch responses at varying response levels and timepoints. Safety measures were assessed throughout the study. Results Superior efficacy in achieving simultaneous EASI 90 and WP-NRS 0/1 response at week 16 was demonstrated with UPA vs. DUPI (19.9% vs 8.9%, respectively; P &amp;lt; 0.001). UPA showed superiority over DUPI for all ranked secondary endpoints, with post hoc analyses exhibiting higher itch response rates as early as day 2. No new safety signals were identified in this period. Conclusions Treatment of moderate-to-severe AD with UPA, initiated at 15 mg and dose-escalated based on clinical response, demonstrated superiority over DUPI per its label for the primary endpoint of simultaneous achievement of near-complete skin clearance (EASI 90) and little-to-no itch (WP-NRS 0/1) at week 16, with all ranked secondary endpoints demonstrating superiority at varying skin and itch response levels and timepoints. No new safety signals were identified vs. the previously reported safety profiles of UPA and DUPI.
Age-associated imbalance in immune cell regeneration varies across individuals and arises from a distinct subset of stem cells
Authors: Anna Nogalska, Jiya Eerdeng, Samir Akre, Mary Vergel-Rodriguez, Yeachan Lee, Charles Bramlett, Adnan Y. Chowdhury, Bowen Wang, Colin G. Cess, Stacey D. Finley, Rong Lu
Journal: Cellular and Molecular Immunology (2024)

Abstract The age-associated decline in immunity manifests as imbalanced adaptive and innate immune cells, which originate from the aging of the stem cells that sustain their regeneration. Aging variation across individuals is well recognized, but its mechanism remains unclear. Here, we used high-throughput single-cell technologies to compare mice of the same chronological age that exhibited early or delayed immune aging phenotypes. We found that some hematopoietic stem cells (HSCs) in early aging mice upregulated genes related to aging, myeloid differentiation, and stem cell proliferation. Delayed aging was instead associated with genes involved in stem cell regulation and the response to external signals. These molecular changes align with shifts in HSC function. We found that the lineage biases of 30% to 40% of the HSC clones shifted with age. Moreover, their lineage biases shifted in opposite directions in mice exhibiting an early or delayed aging phenotype. In early aging mice, the HSC lineage bias shifted toward the myeloid lineage, driving the aging phenotype. In delayed aging mice, HSC lineage bias shifted toward the lymphoid lineage, effectively counteracting aging progression. Furthermore, the anti-aging HSC clones did not increase lymphoid production but instead decreased myeloid production. Additionally, we systematically quantified the frequency of various changes in HSC differentiation and their roles in driving the immune aging phenotype. Taken together, our findings suggest that temporal variation in the aging of immune cell regeneration among individuals primarily arises from differences in the myelopoiesis of a distinct subset of HSCs. Therefore, interventions to delay aging may be possible by targeting a subset of stem cells.
Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Nephrotoxicity: A Position Statement from the American Society of Onco-nephrology
Authors: Sandra M Herrmann, Ala Abudayyeh, Shruti Gupta, Prakash Gudsoorkar, Nattawat Klomjit, Shveta S Motwani, Sabine Karam, Verônica T Costa E Silva, Sheikh B Khalid, Shuchi Anand, Jaya Kala, David E Leaf, Naoka Murakami, Arash Rashidi, Rimda Wanchoo, Abhijat Kitchlu
Journal: Kidney International (2024)
CHK1 attenuates cardiac dysfunction via suppressing SIRT1-ubiquitination
Authors: Tong-Tong Yang, Liu-Hua Zhou, Ling-Feng Gu, Ling-Ling Qian, Yu-Lin Bao, Peng Jing, Jia-Teng Sun, Chong Du, Tian-Kai Shan, Si-Bo Wang, Wen-Jing Wang, Jia-Yi Chen, Ze-Mu Wang, Hao Wang, Qi-Ming Wang, Ru-Xing Wang, Lian-Sheng Wang
Journal: Metabolism (2024)
Periosteum-bone inspired hierarchical scaffold with endogenous piezoelectricity for neuro-vascularized bone regeneration
Authors: Yao Zhao, Yunfan Cai, Wenkai Wang, Yongkang Bai, Mingyi Liu, Yan Wang, Wen Niu, Zhixiao Luo, Lingyun Xia, Juanfang Zhu, Fei Zhao, Franklin R Tay, Lina Niu
Journal: Bioactive Materials (2024)
Pharma pours millions into the NHS for non-research work—but we don’t know what the money is being spent on
Authors: Hristio Boytchev, Piotr Ozieranski, Mostafa Elsharkawy
Journal: BMJ (2024)

Many industry payments to NHS organisations are unexplained and disclosure figures can't be trusted. This raises questions about unrecognised conflicts of interest, find <b>Hristio Boytchev</b>, <b>Piotr Ozieranski</b>, and <b>Mostafa Elsharkawy</b>
Intensive chemotherapy versus standard chemotherapy among patients with high risk, operable, triple negative breast cancer based on integrated mRNA-lncRNA signature (BCTOP-T-A01): randomised, multicentre, phase 3 trial
Authors: Min He, Yi-Zhou Jiang, Yue Gong, Lei Fan, Xi-Yu Liu, Yin Liu, Li-Chen Tang, Miao Mo, Yi-Feng Hou, Gen-Hong Di, Guang-Yu Liu, Ke-Da Yu, Jiong Wu, Xia Yan, Xiao-Hua Zeng, De-Yuan Fu, Chuan-Gui Song, Zhi-Gang Zhuang, Ke-Jin Wu, Jie Wang, Zhong-Hua Wang, Zhi-Ming Shao
Journal: BMJ (2024)

To evaluate the feasibility of using a multigene signature to tailor individualised adjuvant therapy for patients with operable triple negative breast cancer.
TCT-727 The Role of Pulmonary Artery Pulsatility Index to Assess the Outcomes Following Catheter Directed Therapy in Patients With Intermediate-to-High and High-Risk Pulmonary Embolism
Authors: Mario Iannaccone, Sylwia Sławek-Szmyt, Marco Gamardella, Federica Fumarola, Riccardo Mangione, Daniele Savio, Filippo Russo, Giacomo Boccuzzi
Journal: Journal of the American College of Cardiology (2024)
TCT-757 Plaque Morphology According to Optical Coherence Tomography in Patients Undergoing Percutaneous Coronary Intervention for Saphenous Vein Graft Lesions in Acute Coronary Syndrome
Authors: Komal Dahiya, Rajneesh Jain, Ashish Jain, Arun Mohanty, Rajiv Passey
Journal: Journal of the American College of Cardiology (2024)
TCT-703 A CDC WONDER Cohort Analysis of Trends in Mortality in Patients With Peripheral Artery Disease and Cancer
Authors: Irfan Ullah, Abdul Ahad, Owais Ahmad, Hajra Asad, Muhammad Irfan, Abdul Wali Khan, M. Chadi Alraies, Bernardo Cortese
Journal: Journal of the American College of Cardiology (2024)
TCT-728 Catheter-Directed Intervention for High-Risk Acute Pulmonary Embolism in Chronic Kidney Disease
Authors: Manoj Kumar, Priya Hotwani, Shafaqat Ali, Bijeta Keisham, Sanchit Duhan, Faryal Farooq, Sanjay Kumar, Javier Gomez
Journal: Journal of the American College of Cardiology (2024)
TCT-744 Comparison of Effective Radiation Shielding Between a Portable, Configurable, Floor-Supported Radiation Protection System vs Conventional Apron and Shields in Clinical Interventional Procedures
Authors: Leslie Jabloner, Emily Strober, Samia Tamazi, Arber Kodra, Zain Kassam, Alexandra Korn, Tung Ming Leung, Anurag Sharma, Louis Potters, Michael Kim, Christina Brennan, Varinder Singh
Journal: Journal of the American College of Cardiology (2024)
TCT-731 Setting the Stage: Comparative Analysis of Pulmonary Embolism Intervention in the Cath Lab Versus Operating Room
Authors: Ahmed Kazem, Kyle McCullough, Holly Dalton, Joseph Liechty, Chadi Dib, Timothy George, Srinivasa Potluri, Dennis Gable, Molly Szerlip, Sameh Sayfo
Journal: Journal of the American College of Cardiology (2024)
TCT-742 Radiation Hazards and Safety Among Physicians and Allied Health Practitioners (AHP) in Invasive Cardiology Procedures
Authors: F. Aaysha Cader, Ritu Thamman, Sonya Burgess, Sarita Rao, Ing Haan Lim, Ashok Seth, Fazila-Tun-Nesa Malik, Mirvat Alasnag
Journal: Journal of the American College of Cardiology (2024)
TCT-711 Long-term Temporal Association Between Clinical Outcomes and Fractional Flow Reserve After Coronary Stenting: Insights From the International Post-PCI FFR Extended Registry
Authors: Doyeon Hwang, Jaewook Chung, Joo Myung Lee, Chang-Wook Nam, Eun-Seok Shin, Joon-Hyung Doh, Hitoshi Matsuo, Shao-Liang Chen, Tsunekazu Kakuta, Bon-Kwon Koo
Journal: Journal of the American College of Cardiology (2024)
TCT-710 Long-Term Outcomes of IVUS-Guided Femero-Ilio-Caval Stenting for Iliofemoral Venous Outflow Obstruction: A Retrospective Analysis
Authors: Sanchit Kundal, Ali Omar, Hesham Elmariah, Joe Maenza, Maninderjit Ghotra, Ramesh Gowda
Journal: Journal of the American College of Cardiology (2024)